MJManqiu Jin

Manqiu Jin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Manqiu Jin has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Jean Schneikert

    Institute of Allergology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, 12203 Berlin, Germany

    2 shared publications
  • Magda Babina

    Institute of Allergology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany

    2 shared publications
  • Torsten Zuberbier

    Charité – University Medical Center Berlin, Corporate Member of Freie Universität Berlin and Humboldt‐Universität zu Berlin, Institute of Allergology Berlin Germany

    2 shared publications
  • Anja Wegner

    Institute of Allergology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, 12203 Berlin, Germany

    1 shared publication
  • Gürkan Bal

    Institute of Allergology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Hindenburgdamm 30, 12203 Berlin, Germany

    1 shared publication
  • Shiva Raj Tripathi

    Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology IA, 12203 Berlin, Germany

    1 shared publication

Latest Publications

  • Open Access

    Differential Responsiveness of Human Skin Mast Cells to SCF and IL-33: Reduced Reactivity to SCF but Not to IL-33 in the Post-Mitotic Phase

    by Manqiu Jin, Jean Schneikert, Anja Wegner, Torsten Zuberbier, Magda Babina

    Skin mast cells (MCs) play a vital role in acute allergic reactions and also contribute to chronic dermatoses partially through cytokine production. Key growth factors (GFs), such as SCF and IL-33, orchestrate MC survival and activity. Whether early responses differ between these factors remains incompletely defined. In the skin, MCs are long-lived and can proliferate outside the body but eventually exit the cell cycle. It remains unclear whether post-mitotic MCs show altered sensitivity to GFs. MCs were isolated from human foreskin and cultured in the presence of SCF + IL-4. GF-deprived cells were stimulated with either SCF or IL-33. Signaling events were determined by immunoblot. Gene expression was studied by RT-qPCR, cytokine release by ELISA, comparing dividing (3–4 weeks) with post-mitotic “aged” MCs (≥6 weeks). SCF strongly induced genes like FOS, EGR1, and NR4A2, while IL-33 was particularly effective at inducing JUN. IL-33 also prompted significant cytokine production (TNF-α, CCL1 and IL-13), whereas the activation of LIF was confined to SCF. SCF favored KIT, ERK, AKT, and STAT5 activation, whereas IL-33 preferentially stimulated JNK and p38 pathways. Although post-mitotic MCs showed diminished overall responsiveness to SCF, and with interesting differences among modules, their cytokine response to SCF remained comparable. Intriguingly, after exiting the cell cycle, MCs showed heightened sensitivity to IL-33, evidenced by increased ERK activation and TNF-α production. Collectively, IL-33 and SCF elicit markedly different early responses in human skin MCs. Chronic exposure to SCF reduces the responsiveness to this GF without eliminating their reactivity, while non-dividing MCs become more sensitive to IL-33, possibly as a compensatory adaptation.


  • Open Access

    CREB Is Critically Implicated in Skin Mast Cell Degranulation Elicited via FcεRI and MRGPRX2

    by Zhuoran Li, Jean Schneikert, Shiva Raj Tripathi, Manqiu Jin, Gürkan Bal, Torsten Zuberbier, Magda Babina

    Skin mast cells (MCs) mediate acute allergic reactions in the cutaneous environment and contribute to chronic dermatoses, including urticaria, and atopic or contact dermatitis. The cAMP response element binding protein (CREB), an evolutionarily well conserved transcription factor (TF) with over 4,000 binding sites in the genome, was recently found to form a feedforward loop with KIT, maintaining MC survival. The most selective MC function is degranulation with its acute release of prestored mediators. Herein, we asked whether CREB contributes to the expression and function of the degranulation-competent receptors FcεRI and MRGPRX2. Interference with CREB by pharmacological inhibition (CREBi, 666-15) or RNA interference only slightly affected the expression of these receptors, while KIT was strongly attenuated. Interestingly, MRGPRX2 surface expression moderately increased following CREB-knockdown, whereas MRGPRX2-dependent exocytosis simultaneously decreased. FcεRI expression and function were regulated consistently, although the effect was stronger at the functional level. Preformed MC mediators (tryptase, histamine, β-hexosaminidase) remained comparable following CREB attenuation, suggesting that granule synthesis did not rely on CREB function. Collectively, in contrast to KIT, FcεRI and MRGPRX2 moderately depend on unperturbed CREB function. Nevertheless, CREB is required to maintain MC releasability irrespective of stimulus, insinuating that CREB may operate by safeguarding the degranulation machinery. To our knowledge, CREB is the first factor identified to regulate MRGPRX2 expression and function in opposite direction. Overall, the ancient TF is an indispensable component of skin MCs, orchestrating not only survival and proliferation but also their secretory competence.